Hazard
405 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 405 subpotent drug recalls we have scored against our rubric, 19 (5%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 137 (34%) are Severe.
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all subpotent drug recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Acella Pharmaceuticals is recalling NP Thyroid 15 tablets because FDA analysis found the levothyroxine content was less than labeled.
Leadiant Biosciences is recalling 1,380 bottles of Cystaran ophthalmic solution because testing found decreased levels of the active ingredient.
4e Brands North America is recalling blumen hand sanitizer bottles due to methanol contamination and ethanol levels below the labeled claim.
4e Brands North America is recalling Blumen hand sanitizer bottles and pumps found to contain methanol and less ethanol than labeled.
4e Brands North America is recalling Blumen Advanced Hand Sanitizer because testing found methanol contamination and ethanol levels below the labeled claim.
Arbor Pharmaceuticals is voluntarily recalling Nymalize (nimodipine) oral solution because the drug is subpotent. The FDA classifies this as a Class III recall.
RLC Labs Inc. is recalling Nature Throid thyroid medication because FDA analysis found the product to be subpotent.
RLC Labs Inc. is recalling Nature Throid 1.5 Grain thyroid medication because FDA analysis found the product to be subpotent.
RLC Labs Inc. is recalling Nature Throid 2 Grain thyroid medication because FDA analysis found the product to be subpotent.
RLC Labs Inc. is recalling Nature Throid thyroid medication because FDA analysis found the product to be subpotent.
RLC Labs Inc. is recalling Nature Throid 1.25 Grain thyroid medication because FDA analysis found the product to be subpotent.
RLC Labs Inc. is recalling specific lots of WP Thyroid and Westhroid Pure because FDA analysis found the products to be subpotent.
Santa Cruz Biotechnology is recalling 14,238 bottles of UltraCruz Hand Sanitizing Gel because the product is subpotent.
SCA Pharmaceuticals is recalling 3,932 bags of Heparin Sodium 5,000 units due to out-of-specification potency results at the 30-day stability timepoint.
Pharmaceutical Associates, Inc. is recalling Nystatin Oral Suspension because it failed potency testing. Patients should consult their healthcare provider.
Allergan is recalling specific lots of Skin Medica Acne Treatment Lotion because the products failed potency tests at 12 and 24 months.
Beaming White LLC is recalling Koala Hand Sanitizer because the active ingredient ethanol was tested below the label claim and undeclared isopropyl alcohol was present.
Beaming White LLC is recalling Koala Hand Sanitizer because the ethanol content is below the label claim and undeclared isopropyl alcohol is present.
Beaming White LLC is recalling Koala Hand Sanitizer because the ethanol level is below the label claim and it contains undeclared isopropyl alcohol.
Crown Laboratories is recalling 62,274 tubes of Nystatin Cream because the product failed potency testing at the 9-month interval.
Crown Laboratories is recalling Nystatin Cream, USP, because the product failed potency testing at the 9-month interval.
SCA Pharmaceuticals is recalling 333 bags of Heparin Sodium 5,000 units due to out-of-specification potency results at the 30-day stability timepoint.
QuVa Pharma is recalling 648 bags of oxyTOCIN 30 Units/500 mL because the product did not contain the active drug.
Lupin Pharmaceuticals is recalling 4,518 bottles of Cefixime for Oral Suspension because a stability study showed the drug was below the required strength.
Thrive Pharmacy is recalling 403 buprenorphine troches in Florida because they contain less active ingredient than labeled.